Circulating tumor DNA (ctDNA) — genetic material shed from tumors into the bloodstream — may help risk-stratify patients with ...
According to the new study, HIV achieves this with a tissue-specific approach, cloaking itself in a host cell's DNA by ...
Tislelizumab addition to CRT improved survival in ESCC, with group B showing a 1-year PFS rate of 73% and OS rate of 85%. The trial's primary endpoint was PFS, with secondary endpoints including OS, ...
I was taken care of by my dad when she wasn’t around, and while he treated me well, we didn’t connect the same way that I did ...